489 In T2DM, the role of glycemic control in preventing neuropathy is more complex
Since the GLP-1 receptor is expressed on iNKT cells, GLP-1 RAs could induce a dose-dependent inhibition of cytokine secretion by these cells, resulting in improved psoriatic disease [11, 12, 21, 22]
Growth hormone release peaks during deep sleep, providing crucial signals for regeneration
In the landmark SURMOUNT-1 trial published in the New England Journal of Medicine (2022), tirzepatide at the 15 mg dose achieved an average weight loss of 22.5% over 72 weeks
NOTEIf pregnant, consult with your health care provider before use
Figure 1 Data collection and covariates Demographic data collected included age, sex, and body mass index (BMI), which were recorded at baseline